-
Something wrong with this record ?
Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study
J. Drabek, O. Nyc, M. Krutova, J. Stovicek, J. Matejkova, R. Keil,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14209
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
BioMedCentral
from 2002-01-01
BioMedCentral Open Access
from 2002
Directory of Open Access Journals
from 2002
Free Medical Journals
from 2002
PubMed Central
from 2002
Europe PubMed Central
from 2002
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2002-01-01
Open Access Digital Library
from 2002-09-01
Open Access Digital Library
from 2002-01-01
Medline Complete (EBSCOhost)
from 2002-09-16
Health & Medicine (ProQuest)
from 2009-01-01
Public Health Database (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2002
Springer Nature OA/Free Journals
from 2002-01-01
- MeSH
- Survival Analysis MeSH
- Anti-Bacterial Agents administration & dosage adverse effects MeSH
- Clostridioides difficile classification genetics isolation & purification MeSH
- Feces microbiology MeSH
- Clostridium Infections epidemiology microbiology mortality pathology MeSH
- Humans MeSH
- Hospitals, University MeSH
- Polymerase Chain Reaction MeSH
- Diarrhea chemically induced epidemiology microbiology pathology MeSH
- Recurrence MeSH
- Ribotyping * MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Clostridium difficile infection (CDI) is a major cause of antibiotic-associated diarrhoea. Given an increasing CDI incidence and global spread of epidemic ribotypes, a 1-year study was performed to analyse the molecular characteristics of C. difficile isolates and associated clinical outcomes from patients diagnosed with CDI in the Internal Medicine department at University Hospital Motol, Prague from February 2013 to February 2014. RESULTS: A total of 85 unformed stool samples were analysed and CDI was laboratory confirmed in 30 patients (6.8 CDI cases per 10,000 patient bed days and 50.6 CDI cases per 10,000 admissions). The CDI recurrence rate within 3 months of treatment discontinuation was 13.3% (4/30). Mortality within 3 months after first CDI episode was 26.7% (8/30), with CDI the cause of death in two cases. 51.9% of C. difficile isolates belonged to PCR-ribotype 176. MLVA of ribotype 176 isolates revealed two clonal complexes formed by 10/14 isolates. ATLAS scores and Horn's index were higher in patients with ribotype 176 infections than with non-ribotype 176 infections. CONCLUSION: This study highlights the clinical relevance of C. difficile PCR-ribotype 176 and its capacity to spread within a healthcare facility.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16009896
- 003
- CZ-PrNML
- 005
- 20181210110409.0
- 007
- ta
- 008
- 160408s2015 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12941-015-0114-0 $2 doi
- 024 7_
- $a 10.1186/s12941-015-0114-0 $2 doi
- 035 __
- $a (PubMed)26698842
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Drábek, Jiří $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. jiri.drabek@lfmotol.cuni.cz. $7 xx0067365
- 245 10
- $a Clinical features and characteristics of Clostridium difficile PCR-ribotype 176 infection: results from a 1-year university hospital internal ward study / $c J. Drabek, O. Nyc, M. Krutova, J. Stovicek, J. Matejkova, R. Keil,
- 520 9_
- $a BACKGROUND: Clostridium difficile infection (CDI) is a major cause of antibiotic-associated diarrhoea. Given an increasing CDI incidence and global spread of epidemic ribotypes, a 1-year study was performed to analyse the molecular characteristics of C. difficile isolates and associated clinical outcomes from patients diagnosed with CDI in the Internal Medicine department at University Hospital Motol, Prague from February 2013 to February 2014. RESULTS: A total of 85 unformed stool samples were analysed and CDI was laboratory confirmed in 30 patients (6.8 CDI cases per 10,000 patient bed days and 50.6 CDI cases per 10,000 admissions). The CDI recurrence rate within 3 months of treatment discontinuation was 13.3% (4/30). Mortality within 3 months after first CDI episode was 26.7% (8/30), with CDI the cause of death in two cases. 51.9% of C. difficile isolates belonged to PCR-ribotype 176. MLVA of ribotype 176 isolates revealed two clonal complexes formed by 10/14 isolates. ATLAS scores and Horn's index were higher in patients with ribotype 176 infections than with non-ribotype 176 infections. CONCLUSION: This study highlights the clinical relevance of C. difficile PCR-ribotype 176 and its capacity to spread within a healthcare facility.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antibakteriální látky $x aplikace a dávkování $x škodlivé účinky $7 D000900
- 650 _2
- $a klostridiové infekce $x epidemiologie $x mikrobiologie $x mortalita $x patologie $7 D003015
- 650 _2
- $a Clostridioides difficile $x klasifikace $x genetika $x izolace a purifikace $7 D016360
- 650 _2
- $a průjem $x chemicky indukované $x epidemiologie $x mikrobiologie $x patologie $7 D003967
- 650 _2
- $a feces $x mikrobiologie $7 D005243
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a nemocnice univerzitní $7 D006785
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a recidiva $7 D012008
- 650 12
- $a ribotypizace $7 D021521
- 650 _2
- $a analýza přežití $7 D016019
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nyč, Otakar $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. otakar.nyc@lfmotol.cuni.cz. $7 uk2007399535
- 700 1_
- $a Krůtová, Marcela $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. marcela.krutova@seznam.cz. DNA Laboratory, Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. marcela.krutova@seznam.cz. $7 xx0191653
- 700 1_
- $a Šťovíček, Jan $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. jan.stovicek@fnmotol.cz. $7 xx0093415
- 700 1_
- $a Matějková, Jana $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic. jana.matejkova@lfmotol.cuni.cz. $7 xx0209775
- 700 1_
- $a Keil, Radan, $u Department of Internal Medicine, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06, V Uvalu 84, Praha 5, Prague, Czech Republic. Radan.Keil@fnmotol.cz. $d 1961- $7 jn20000401330
- 773 0_
- $w MED00008163 $t Annals of clinical microbiology and antimicrobials $x 1476-0711 $g Roč. 14, č. - (2015), s. 55
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26698842 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20181210110530 $b ABA008
- 999 __
- $a ok $b bmc $g 1113325 $s 934264
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 14 $c - $d 55 $e 20151223 $i 1476-0711 $m Annals of clinical microbiology and antimicrobials $n Ann Clin Microbiol Antimicrob $x MED00008163
- GRA __
- $a NT14209 $p MZ0
- LZP __
- $a Pubmed-20160408